221 related articles for article (PubMed ID: 11350898)
1. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.
El-Assal ON; Yamanoi A; Ono T; Kohno H; Nagasue N
Clin Cancer Res; 2001 May; 7(5):1299-305. PubMed ID: 11350898
[TBL] [Abstract][Full Text] [Related]
2. [Expression of heparanase mRNA and its clinical significance in primary hepatocellular carcinoma].
Zhang YL; Fu ZR; Ding GS; Fu H; Wang YH; Wang Q
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):359-61. PubMed ID: 12921566
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas.
Mikami S; Ohashi K; Katsube K; Nemoto T; Nakajima M; Okada Y
Pathol Int; 2004 Aug; 54(8):556-63. PubMed ID: 15260846
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
[TBL] [Abstract][Full Text] [Related]
5. [Expression rates of three angiogenic factors in hepatocellular carcinoma and their relation with microvessel density and portal vein tumor thrombosis].
Zhou J; Tang Z; Fan J
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(8):462-4. PubMed ID: 11798918
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
J Surg Oncol; 2002 Nov; 81(3):148-54; disscusion 154. PubMed ID: 12407728
[TBL] [Abstract][Full Text] [Related]
8. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
Zhao WB; Li Y; Liu X; Zhang LY; Wang X
Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma.
Poon RT; Lau CP; Ho JW; Yu WC; Fan ST; Wong J
Clin Cancer Res; 2003 Nov; 9(14):5339-45. PubMed ID: 14614019
[TBL] [Abstract][Full Text] [Related]
14. [Expression of basic fibroblastic growth factor and microvessel density in endometrial carcinoma].
Bai X; Mi R
Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):348-51. PubMed ID: 11776176
[TBL] [Abstract][Full Text] [Related]
15. Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma.
Zhang Y; Li L; Wang Y; Zhang J; Wei G; Sun Y; Shen F
Biochem Biophys Res Commun; 2007 Jun; 358(1):124-9. PubMed ID: 17467664
[TBL] [Abstract][Full Text] [Related]
16. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma.
Poon RT; Chung KK; Cheung ST; Lau CP; Tong SW; Leung KL; Yu WC; Tuszynski GP; Fan ST
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4150-7. PubMed ID: 15217952
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
[TBL] [Abstract][Full Text] [Related]
19. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
[TBL] [Abstract][Full Text] [Related]
20. [Intratumoral microvessel density and expression of vascular endothelial growth factor in hepatocellular carcinoma after chemoembolization].
Shao G; Wang J; Zhou K; Yan Z
Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):170-3. PubMed ID: 12113668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]